132 related articles for article (PubMed ID: 2430686)
1. Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma. Potential for cure and preservation of reproductive capacity.
Gershenson DM; Wharton JT; Kline RC; Larson DM; Kavanagh JJ; Rutledge FN
Cancer; 1986 Dec; 58(12):2594-9. PubMed ID: 2430686
[TBL] [Abstract][Full Text] [Related]
2. Ovarian dysgerminoma with massive metastases to para-aortic lymph nodes.
Takemori M; Ichimura T; Nishimura R; Hasegawa K
Gynecol Obstet Invest; 2000; 49(3):211-3. PubMed ID: 10729765
[TBL] [Abstract][Full Text] [Related]
3. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.
Brewer M; Gershenson DM; Herzog CE; Mitchell MF; Silva EG; Wharton JT
J Clin Oncol; 1999 Sep; 17(9):2670-75. PubMed ID: 10561340
[TBL] [Abstract][Full Text] [Related]
4. Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature.
Jeyakumar A; Cabeza R; Hindenburg A
Gynecol Oncol; 2001 May; 81(2):314-7. PubMed ID: 11330968
[TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.
Gershenson DM; Morris M; Cangir A; Kavanagh JJ; Stringer CA; Edwards CL; Silva EG; Wharton JT
J Clin Oncol; 1990 Apr; 8(4):715-20. PubMed ID: 1690272
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.
Williams SD; Blessing JA; Hatch KD; Homesley HD
J Clin Oncol; 1991 Nov; 9(11):1950-5. PubMed ID: 1719142
[TBL] [Abstract][Full Text] [Related]
7. Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine, and bleomycin.
Jacobs AJ; Harris M; Deppe G; DasGupta I; Cohen CJ
Obstet Gynecol; 1982 Jan; 59(1):129-32. PubMed ID: 6176923
[TBL] [Abstract][Full Text] [Related]
8. PVB chemotherapy in patients with recurrent or advanced dysgerminoma: a Phase II study of the EORTC Gynaecological Cancer Cooperative Group.
Pawinski A; Favalli G; Ploch E; Sahmoud T; van Oosterom AT; Pecorelli S
Clin Oncol (R Coll Radiol); 1998; 10(5):301-5. PubMed ID: 9848330
[TBL] [Abstract][Full Text] [Related]
9. Recurrent ovarian dysgerminoma after laparoscopy.
Prado S; Yazigi R; Garrido J; Gonzalez M; Torres R; Oddo D
Int J Gynecol Cancer; 2006; 16 Suppl 1():397-9. PubMed ID: 16515632
[TBL] [Abstract][Full Text] [Related]
10. Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission.
Kanazawa K; Suzuki T; Sakumoto K
Am J Clin Oncol; 2000 Jun; 23(3):244-8. PubMed ID: 10857886
[TBL] [Abstract][Full Text] [Related]
11. [A case of PEP(BEP)-resistant ovarian dysgerminoma successfully treated by VeIP therapy].
Ishibashi M; Nakayama K; Oride A; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gan To Kagaku Ryoho; 2009 Mar; 36(3):513-7. PubMed ID: 19295284
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
Williams SD; Blessing JA; Moore DH; Homesley HD; Adcock L
Ann Intern Med; 1989 Jul; 111(1):22-7. PubMed ID: 2472080
[TBL] [Abstract][Full Text] [Related]
13. Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85/90/95) with late effects study.
Duhil de Bénazé G; Pacquement H; Faure-Conter C; Patte C; Orbach D; Corradini N; Berger C; Sudour-Bonnange H; Vérité C; Martelli H; Fresneau B
Eur J Cancer; 2018 Mar; 91():30-37. PubMed ID: 29331749
[TBL] [Abstract][Full Text] [Related]
14. Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary.
Kasenda B; Harter P; Hirsch T; Ast A; Buhrmann C; Glaser F; Du Bois A
Acta Obstet Gynecol Scand; 2009; 88(11):1288-90. PubMed ID: 19900144
[TBL] [Abstract][Full Text] [Related]
15. A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies.
Smith EB; Clarke-Pearson DL; Creasman WT
Am J Obstet Gynecol; 1984 Dec; 150(8):927-31. PubMed ID: 6542313
[TBL] [Abstract][Full Text] [Related]
16. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
17. Prolonged chemotherapeutic remission and possible cure of metastatic dysgerminoma.
Cohen SM; Goldsmith MA
Gynecol Oncol; 1987 Oct; 28(2):236. PubMed ID: 2444503
[No Abstract] [Full Text] [Related]
18. Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatin.
Gershenson DM; Kavanagh JJ; Copeland LJ; Del Junco G; Cangir A; Saul PB; Stringer CA; Edwards CL; Wharton JT
Cancer; 1986 May; 57(9):1731-7. PubMed ID: 2420435
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.
Williams SD; Kauderer J; Burnett AF; Lentz SS; Aghajanian C; Armstrong DK
Gynecol Oncol; 2004 Dec; 95(3):496-9. PubMed ID: 15581952
[TBL] [Abstract][Full Text] [Related]
20. Ovarian sertoli-leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients.
Akman L; Ertas IE; Gokcu M; Terek MC; Sanci M; Sanli UA; Zekioglu O; Ozsaran AA
J Cancer Res Ther; 2016; 12(1):290-4. PubMed ID: 27072253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
